Heparin: 100 years of pleiotropic effects. - Wikidata - awgldk - TriplyDB

Heparin: 100 years of pleiotropic effects.

Heparin: 100 years of pleiotropic effects.

http://www.wikidata.org/entity/Q38588071

about

Unfractionated heparin after TBI reduces in vivo cerebrovascular inflammation, brain edema and accelerates cognitive recovery.

P2860

Q47098860-5AAB36C6-FFE4-4C69-8EC6-CBA61BE18481

P2860

Heparin: 100 years of pleiotropic effects.

http://www.wikidata.org/entity/Q38588071

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Heparin: 100 years of pleiotropic effects.

@en

type

label

Heparin: 100 years of pleiotropic effects.

@en

prefLabel

Heparin: 100 years of pleiotropic effects.

@en

P1433

Q38588071-AC4F9470-E0BB-458B-9EE2-8DBC68177583

P1476

Q38588071-A1706779-9909-4345-8F00-B0B48CE277F9

P2093

Q38588071-8397606A-7C6A-4F77-A7F2-55743533F6DF

P2860

Q38588071-05107664-CEC9-4205-87E2-86C3B169E3F9

Q38588071-1977D50D-65FC-43BF-A137-93F2E45DC8E5

Q38588071-2484F07A-D9F6-483B-BDA3-AB7040A4A4B4

Q38588071-394FE627-0122-43D8-8EC1-065CDBBD15D8

Q38588071-3C0CA17E-BDE2-4DCD-9C12-B61356A53780

Q38588071-449B8B18-7DE2-4E37-B8C9-FD517267DF3E

Q38588071-44A68AEC-FCCE-465A-A3A3-03BF52F88925

Q38588071-479044BD-F70F-4994-A955-1F42F30AF8BE

Q38588071-4A0881A4-F927-4034-88F7-5978A32C6617

Q38588071-4F2DEF4D-F9B2-4941-9602-EEEE38B79E1B

P2888

Q38588071-75478FEC-3CA6-46ED-BD9A-BA6AF56E8ACB

P304

Q38588071-5E299AA5-4737-484C-8DF6-E1C313980F10

P31

Q38588071-42309F94-BEDC-4552-914D-928F7CE7EC9B

P356

Q38588071-A86FC6EE-17B0-4776-A400-2856EA4506F6

P433

Q38588071-92F7A981-5B8A-4EE4-906C-E1430A3A90B5

P478

Q38588071-F720B8DD-9E9F-4A19-B155-D98999FD11F7

P577

Q38588071-D10689EF-CBB7-48EF-A711-30D7E695DCA0

P698

Q38588071-992A3814-7366-4567-9C44-CE8C9DD9F07E

P356

S11239-015-1261-Z

P1433

Journal of Thrombosis and Thrombolysis

P1476

Heparin: 100 years of pleiotropic effects.

@en

P2093

Adilson Ferraz Paschoa

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials

Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials

Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severity

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Treatment of established thrombotic events in patients with cancer.

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group.

Asthma and coagulation.

P2888

s11239-015-1261-z

P304

636-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11239-015-1261-Z

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26377359

http://www.w3.org/2001/XMLSchema#string